Free Trial
OTCMKTS:CMXC

Cell MedX (CMXC) Stock Price, News & Analysis

Cell MedX logo
$0.03 0.00 (0.00%)
(As of 11/20/2024 ET)

About Cell MedX Stock (OTCMKTS:CMXC)

Key Stats

Today's Range
$0.03
$0.03
50-Day Range
$0.01
$0.49
52-Week Range
$0.00
$0.23
Volume
7,188 shs
Average Volume
20,342 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. It also develops eBalance Home and eBalance Pro System for temporary relief of shoulder, waist, back, neck, arms, and legs. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is headquartered in Carson City, Nevada.

Receive CMXC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cell MedX and its competitors with MarketBeat's FREE daily newsletter.

CMXC Stock News Headlines

Cell MedX Corp. (CMXC)
The best cell phone plans in 2024
Blackrock’s Sending THIS Crypto Higher on Purpose
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
Cells, organ systems and ecosystems
CMXC Cell MedX Corp.
Cell structure - AQA Microscopes
Cell biology
Cell MedX Corp CMXC
See More Headlines

CMXC Stock Analysis - Frequently Asked Questions

Cell MedX's stock was trading at $0.0220 at the start of the year. Since then, CMXC stock has increased by 41.4% and is now trading at $0.0311.
View the best growth stocks for 2024 here
.

Shares of CMXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cell MedX investors own include Callon Petroleum (CPE), Ashford Hospitality Trust (AHT), Peabody Energy (BTU), Himax Technologies (HIMX), Remark (MARK), MicroVision (MVIS) and Ritter Pharmaceuticals (RTTR).

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
Retail
Current Symbol
OTCMKTS:CMXC
Previous Symbol
NASDAQ:CMXC
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

This page (OTCMKTS:CMXC) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners